The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation and determine relationship to the disease course. Cross-comparisons among the disorders will allow us to better evaluate mechanisms of renal dysfunction in these disorders.
Severe, hereditary forms of nephrolithiasis cause marked excretion of insoluble minerals important in stone formation, including primary hyperoxaluria, cystinuria, Dent disease, and adenine phosphoribosyltransferase deficiency (APRTd). Patients with these disorders experience recurring stones from childhood and are at high risk for chronic kidney disease caused by crystal nephropathy. Enteric hyperoxaluria is an acquired disease characterized by hyperoxaluria and calcium oxalate crystal nephropathy associated with chronic kidney disease, and in that respect similar to the inherited stone diseases. The investigators will collect longitudinal data of individual patients in order to provide clues about potentially modifiable factors that influence disease severity and identify factors leading to kidney injury. the investigator will measure blood and urinary markers of inflammation and determine relationship to the disease course. Cross-comparisons among the disorders will allow to better evaluate mechanisms of renal dysfunction in these diseases.
Study Type
OBSERVATIONAL
Enrollment
220
University of Alabama @ Birmingham
Birmingham, Alabama, United States
NOT_YET_RECRUITINGMayo Clinic Jacksonville
Jacksonville, Florida, United States
NOT_YET_RECRUITINGChildren's Memorial Hospital
Chicago, Illinois, United States
NOT_YET_RECRUITINGChildren's Hospital, Harvard Medical School
Boston, Massachusetts, United States
NOT_YET_RECRUITINGMayo Clinic Hyperoxaluria Center
Rochester, Minnesota, United States
RECRUITINGNew York University
New York, New York, United States
NOT_YET_RECRUITINGCincinnati Children's Hosptial Medical Center
Cincinnati, Ohio, United States
NOT_YET_RECRUITINGChildren's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
NOT_YET_RECRUITINGHosptial of Sick Children
Toronto, Ontario, Canada
NOT_YET_RECRUITINGLandspitali Universtiy Hospital
Reykjavik, Iceland
NOT_YET_RECRUITING...and 1 more locations
inflammatory blood and urinary biomarkers
Statistically significant changes (increase or decrease) in inflammatory urinary biomarkers compared to reference values
Time frame: Annually for 5 years
Longitudinal changes in eGFR
changes in eGFR during the 5 years
Time frame: Annually for 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.